Mulavelil Rachel, Finny Philip, David Alice, Samuel Preethy S, Armstrong Lois J
Department of Population Neuroscience Research, Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, Texas, USA.
Department of Endocrinology, Believers Church Medical College Hospital, Kerala, India.
Indian J Endocrinol Metab. 2022 May-Jun;26(3):234-238. doi: 10.4103/ijem.ijem_430_21. Epub 2022 Apr 29.
Glucocorticoids (GCs) are anti-inflammatory steroid medications prescribed globally by doctors for various illnesses and they are known to produce quick symptom relief. In India, they are among the cheapest and easily accessible over-the-counter medications. Thus, it can be misused, leading to many life-threatening illnesses such as diabetes mellitus, hypertension, overwhelming infections, Cushing's syndrome, and hypo-adrenal crisis.
This study reports the misuse of GCs in a rural community in the state of Kerala, India, and compares it with the only other community GC misuse study in India, from the state of Bihar.
A community-based cross-sectional survey of 452 households comprising 1,734 people was conducted in rural Konni, Kerala, during June and July of 2019. In each house, people who had been taking medications over the previous 6 months were interviewed.
Almost 2% ( = 31) had consumed one or more GCs in the last 6 months (95% CI: 1.3-2.5%). Of these, 26% ( = 8) were taking oral GCs and 36% ( = 11) of them were inappropriately using them based on current clinical guidelines. 29% ( = 9) had used GCs for more than 1 month.
GC misuse exists in Kerala but not to the extent seen in Bihar. In Kerala, inhaled GCs are more common than oral GCs, and the prescription is obtained predominantly from qualified medical practitioners. The prevalence of prolonged GC use could be implicated as an underlying factor for diabetes, hypertension, osteoporosis, and cataracts. It is possible that approximately 220,000 people in Kerala may have a suppressed hypothalamus-pituitary-adrenal axis which can predispose them to a fatal hypo-adrenal crisis.
糖皮质激素(GCs)是一类抗炎甾体药物,全球医生都用其治疗各种疾病,且已知能迅速缓解症状。在印度,它们是最便宜且易于获得的非处方药之一。因此,可能会被滥用,导致许多危及生命的疾病,如糖尿病、高血压、严重感染、库欣综合征和肾上腺皮质功能减退危象。
本研究报告了印度喀拉拉邦一个农村社区中糖皮质激素的滥用情况,并将其与印度比哈尔邦唯一一项关于社区糖皮质激素滥用的研究进行比较。
2019年6月至7月,在喀拉拉邦农村的科尼对452户家庭(共1734人)进行了一项基于社区的横断面调查。在每户家庭中,对过去6个月内服用过药物的人进行访谈。
近2%(n = 31)的人在过去6个月内服用过一种或多种糖皮质激素(95%置信区间:1.3 - 2.5%)。其中,26%(n = 8)正在服用口服糖皮质激素,根据当前临床指南,36%(n = 11)的人使用不当。29%(n = 9)使用糖皮质激素超过1个月。
喀拉拉邦存在糖皮质激素滥用情况,但程度不如比哈尔邦。在喀拉拉邦,吸入性糖皮质激素比口服糖皮质激素更常见,且处方主要来自合格的医生。长期使用糖皮质激素的患病率可能是糖尿病、高血压、骨质疏松症和白内障的潜在因素。喀拉拉邦可能约有22万人下丘脑 - 垂体 - 肾上腺轴受到抑制,这可能使他们易患致命的肾上腺皮质功能减退危象。